Axovan
Switzerland
acquired
acquired
Stage
About
Axovan was a Swiss drug development company focused on cardiovascular therapies; it was acquired by Actelion in 2004 for up to CHF252 million.
Explore Axovan's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.